Scynexis (SCYX) Market Capitalization (2014 - 2026)
Scynexis' (SCYX) quarterly Market Capitalization came in at $40.5 million in Q2 2026, up 20.64% on a YoY basis from $33.6 million in Q2 2025, and down 13.33% quarter-over-quarter from $46.7 million in Q1 2026.
Analysis
Scynexis (SCYX) Market Capitalization (2014 - 2026) Analysis & Trends
Scynexis (SCYX) has reported Market Capitalization for 13 consecutive years, with $40.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Market Capitalization rose 20.64% year-over-year to $40.5 million; the trailing twelve-month figure through Jun 2026 stood at $40.5 million (up 20.64% YoY), and the FY2025 full-year result was $27.5 million, down 53.09% from the prior year.
- Market Capitalization eased to $40.5 million in Q2 2026 per SCYX's latest filing, from $46.7 million in the prior quarter.
- Across five years, Market Capitalization topped out at $143.3 million in Q1 2023 and bottomed at $27.5 million in Q4 2025.
- Historically, Market Capitalization has averaged $77.9 million across 5 years, with a median of $71.7 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Market Capitalization soared 75.28% in 2023, then tumbled 65.4% in 2025.
- Over 5 years, Market Capitalization stood at $66.5 million in 2022, then surged by 60.52% to $106.7 million in 2023, then tumbled by 44.99% to $58.7 million in 2024, then sank by 53.09% to $27.5 million in 2025, then soared by 47.07% to $40.5 million in 2026.
- According to Business Quant data, Market Capitalization over the past three periods registered $40.5 million, $46.7 million, and $27.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.49 Mn |
| Mar 31, 2026 | 46.72 Mn |
| Dec 31, 2025 | 27.53 Mn |
| Sep 30, 2025 | 32.31 Mn |
| Jun 30, 2025 | 33.57 Mn |
| Mar 31, 2025 | 47.07 Mn |
| Dec 31, 2024 | 58.70 Mn |
| Sep 30, 2024 | 72.44 Mn |
| Jun 30, 2024 | 97.02 Mn |
| Mar 31, 2024 | 70.92 Mn |
| Dec 31, 2023 | 106.71 Mn |
| Sep 30, 2023 | 109.19 Mn |
| Jun 30, 2023 | 141.12 Mn |
| Mar 31, 2023 | 143.27 Mn |
| Dec 31, 2022 | 66.48 Mn |
| Sep 30, 2022 | 114.01 Mn |
| Jun 30, 2022 | 80.51 Mn |
| Mar 31, 2022 | 114.25 Mn |
| Dec 31, 2021 | 175.10 Mn |
| Sep 30, 2021 | 126.59 Mn |